Target intelligence / Profile preview

TM4SF19 antisense RNA 1 (TM4SF19-AS1)

Target
TM4SF19-AS1
Molecular classification
Long non-coding RNA
01

Overview

TM4SF19 antisense RNA 1 (TM4SF19-AS1) is a long non-coding RNA that does not encode a protein. It is highly expressed in head and neck squamous cell carcinoma (HNSCC) cells and tissues. Functional studies show that its knockdown impairs cell proliferation, migration, invasion, and epithelial-mesenchymal transition in HNSCC cell lines, as well as tumor growth in vivo. Mechanistically, TM4SF19-AS1 acts in the cytoplasm as a competing endogenous RNA (ceRNA), sponging microRNA-153-3p to upregulate its target LAMC1, and also interacts with the RNA-binding protein HNRNPC to stabilize LAMC1 mRNA. These results suggest TM4SF19-AS1 plays an oncogenic role in HNSCC and may be of clinical value as a novel biomarker, but it is not considered a classical therapeutic target like a receptor, enzyme, or transporter[1][3].

Other names
TM4SF19-AS1TM4SF19 antisense RNA 1 (non-protein coding)
02

Biological functions

Regulation of cell proliferationRegulation of cell migrationRegulation of cell invasionEpithelial-mesenchymal transition (EMT) regulationCompeting endogenous RNA (ceRNA) activity (miRNA sponge)
03

Disease associations

Cancer (specifically head and neck squamous cell carcinoma)
04

Biomarkers

Potential biomarker for diagnosis or prognosis in head and neck squamous cell carcinoma

Beyond the preview

Go deeper on TM4SF19 antisense RNA 1 (TM4SF19-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TM4SF19 antisense RNA 1 (TM4SF19-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call